(no text — see the shared post below)
Metformin associated with over 50% lower dementia risk in 20-year DPP/DPPOS follow-up
Louis shares a New Scientist report on observational analysis of the Diabetes Prevention Program randomized trial and its follow-up, suggesting metformin may cut dementia risk by more than half. It aligns with monkey data on slower brain aging. The finding is not conclusive and the mechanism is unclear.




